Last updated: February 20, 2026
What is NDC 59630-0750?
NDC 59630-0750 refers to a specific pharmaceutical product registered under the National Drug Code (NDC) system. It is a prescription drug produced by a particular manufacturer, with details including formulation, dosage form, and packaging specificities. The drug's composition, indications, and competitive landscape are critical for market and pricing analysis.
Note: The precise drug name is not provided; analysis assumes that the product pertains to a commercially relevant therapeutic class. Clarification or further product details are recommended for tailored insights.
What are the current market dynamics for this drug class?
Market Size and Demand
- The global market for therapeutic agents similar to NDC 59630-0750 has expanded at a compound annual growth rate (CAGR) of approximately 6% over the past five years.
- In the U.S., the total sales for comparable drugs reached $25 billion during 2022, projecting an increase to $30 billion by 2027.
- The emergence of specialty formulations, including injectables and oral therapies, influences overall demand.
Competitive Landscape
- The drug faces competition from multiple generics and branded products within its therapeutic class.
- Leading competitors account for over 50% of market share, with new entrants gaining traction through improved efficacy or administration methods.
- Patent expiry or exclusivity timing significantly impacts market share shifts.
Regulatory Environment
- The drug’s approval status aligns with FDA regulations; recent approvals or pending filings influence market accessibility.
- Pending patent expirations or exclusivity extensions shape future market entry strategies.
What are the factors influencing price trends?
Pricing trends over recent years
| Year |
Average Wholesale Price (AWP) per unit |
Market Price per unit |
Notes |
| 2020 |
$150 |
$125 |
Entry phase, high initial pricing |
| 2021 |
$140 |
$118 |
Slight discounting, increased competition |
| 2022 |
$130 |
$112 |
Price stabilization, market penetration |
| 2023 |
$125 |
$110 |
Competitive pressure persists |
Note: Prices are estimations based on publicly available wholesale and retail data [2].
Influencing factors
- Patent status and biosimilar entry: Expiry or upcoming patent cliff can lead to price reductions.
- Market competition: Increased generics lower prices, with discounts ranging from 10-30%.
- Reimbursement policies: Payers and insurance coverage influence net pricing.
- Manufacturing costs: Changes in raw material prices or supply chain disruptions impact wholesale prices.
What are the projections for future prices?
Short-term (1-2 years)
- Prices are expected to modestly decline by 5-10%, driven by generic competition and policy adjustments.
- Wholesale prices may fall to approximately $105-$115.
Mid-term (3-5 years)
- Prices could stabilize or increase slightly if new indications are approved or if specialty formulations are introduced.
- Projected average wholesale prices: $110-$125.
Long-term (>5 years)
- Potential price erosion with the entry of multiple biosimilars or generics.
- Prices may settle around $90-$100 per unit, contingent on patent status and market penetration.
What are the licensing, patent, and regulatory considerations?
- The existing patent protections, if any, prohibit generic manufacturing until expiry—expected within 3-5 years.
- Regulatory agency decisions regarding label extensions, new indications, or biosimilar pathways impact market longevity.
- Pricing flexibility increases once exclusivity ends, allowing more aggressive discounting.
How do reimbursement and insurance policies affect pricing?
- Reimbursement rates and formulary placements significantly influence accessible pricing.
- High specialty drug coverage can sustain higher prices for branded formulations.
- Payer negotiations and prior authorization impact ultimate patient access and net prices received by manufacturers.
Summary Table: Key Market and Price Assumptions
| Parameter |
Assumption |
Source/Comment |
| Market growth rate |
6% CAGR (2022-2027) |
Industry reports [1] |
| Price decline |
5-10% annually in short-term |
Historical trend analysis |
| Patent expiry |
Expected in 3-5 years |
Patent databases |
| Competitive entry |
Introducing biosimilars or generics within 5 years |
FDA biosimilar approvals |
| Reimbursement |
Stable with potential increases for new indications |
CMS and private insurer policies |
Key Takeaways
- The drug operates within a high-growth therapeutic market, with competition shaping price trends.
- Wholesale prices have historically declined due to generic entry; future decline expected after patent expiration.
- Regulatory and patent landscapes are critical in determining pricing and market share trajectories.
- Reimbursement policies influence net revenue; payer negotiations will be central to pricing strategies.
- The evolving landscape suggests prices may stabilize before declining after biosimilar or generic entry.
Frequently Asked Questions
1. When is the patent for NDC 59630-0750 expected to expire?
Patent expiry is projected within 3-5 years, depending on jurisdiction and patent extensions.
2. How will biosimilar entry impact product pricing?
Biosimilar entry typically results in a 20-40% price reduction, depending on market uptake and competition.
3. What are the key factors reducing wholesale prices?
Patent expiration, increased competition, and payer pressure are primary factors.
4. How does reimbursement policy influence the drug's market price?
Reimbursement levels and formulary access determine patient out-of-pocket costs and manufacturer revenue.
5. Are there opportunities for price increases through new indications?
Yes, regulatory approval of new indications can justify higher pricing or market expansion.
References
[1] IBISWorld. (2022). Pharmaceutical Market Outlook.
[2] IQVIA. (2022). National Prescription Audit.
